LRCX
Lam Research · Technology · $75B · NASDAQ · ✓ halal
Stage 2, RS +17% vs SPY, at 52-wk highs (98%). Earnings Apr 22; DB raised PT to $300; EPS expected +31% YoY. RSI 64.6 healthy. Volume 0.84× slightly low — the $272 level has acted as resistance on prior attempts; volume confirmation on a close above it would be notable. Semi-cap equipment sector continues to lead on HBM demand.
- ⚠️breakout98% of 52-wk range; volume has not yet confirmed a sustained close above $272.
- ❌pullbackStage 2 but RSI 65 — no meaningful pullback currently present.
- ⚠️earnings-driftEarnings Apr 22 — pre-earnings period historically volatile.
- ✅trend-continuationStage 2 + RS +17% + rising 50-SMA + healthy RSI — textbook trend-continuation conditions.
- ✅sector-rotationSemis leading the tape; LRCX +20% 3M; sector and stock both outperforming.
The card above is research output, not a recommendation to trade. Classifications are generic market commentary available to all subscribers equally — not personalized investment advice.